AngioDynamics tops estimates as revenue rises and losses narrow, driven by Med Tech demand, even as gross margin slips.

AngioDynamics tops estimates as revenue rises and losses narrow, driven by Med Tech demand, even as gross margin slips.

Morgan Stanley's Q1 2026 EPS jumps 32% and beats estimates as advisory revenues surge 74% and equity trading hits a record, lifting shares premarket.

JBHT beats Q1 estimates as revenues rise 4.6% and EPS jumps 27%, led by record Intermodal volume and productivity-driven margin gains.

DAL beats Q1 estimates with 39% EPS growth and rising revenues, as strong passenger demand and unit revenue gains drive performance.

BB tops fiscal Q4 2026 estimates as QNX and Secure Comms drive revenue beat. Strong fiscal 2027 outlook signals growth across key segments.

BB tops fiscal Q4 2026 estimates as QNX and Secure Comms drive revenue beat. Strong fiscal 2027 outlook signals growth across key segments.

PNC's Q1 earnings beat estimates, driven by higher NII, margin expansion and loan growth after the FirstBank acquisition.

LEVI posts Q1 beats on EPS and revenues, driven by strong DTC and e-commerce growth, while raising its fiscal 2026 outlook.

Mama's Creations eyes sharp Q4 gains as revenues are seen up 62.9% and EPS up 25% ahead of April 14 results.